ADVFN - Advanced Financial Network.
HOME» NYSE » G » GSK Stock Price » GSK Stock News

Glaxosmithkline Share News

 Glaxosmithkline Stock Price
GSK Stock Price
 Glaxosmithkline Stock Chart
GSK Stock Chart
 Glaxosmithkline Stock News
GSK Stock News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Stock Trades
GSK Stock Trades

GlaxoSmithKline Buys 1.5 Million Own Shares for Treasury

LONDON--GlaxoSmithKline PLC (GSK.LN) said Wednesday it bought 1.5 million of its own shares to be held in treasury. MAIN FACTS: -Highest price per share 1,466.5 pence -Lowest price 1,452.0 pence -Shares closed Wednesday at 1455 pence valuing the company at GBP73 billion. -Write to Ed Ballard at [email protected]

Stock News for Glaxosmithkline (GSK)
02/23/201710:54:45Report of Foreign Issuer (6-k)
02/23/201708:17:39Report of Foreign Issuer (6-k)
02/23/201706:05:00GlaxoSmithKline Reports Positive Study Results for Asthma Drug
02/23/201705:00:00Positive Results for Relvar® Ellipta® Lung Function Study in P...
02/23/201704:37:00PureTech Health Appoints Atul Pande as Chief Medical Officer
02/22/201710:44:43Report of Foreign Issuer (6-k)
02/21/201713:50:45Report of Foreign Issuer (6-k)
02/21/201713:38:00Korn Ferry Futurestep Partners with GlaxoSmithKline to Support...
02/21/201706:31:29Report of Foreign Issuer (6-k)
02/21/201706:30:06Report of Foreign Issuer (6-k)
02/17/201713:23:13Report of Foreign Issuer (6-k)
02/17/201713:15:27Report of Foreign Issuer (6-k)
02/17/201711:58:41Report of Foreign Issuer (6-k)
02/16/201704:07:00Vectura Group Hits GBP9 Million Royalty Target on Glaxo's Ellipta...
02/15/201713:02:55Report of Foreign Issuer (6-k)
02/14/201709:02:55Report of Foreign Issuer (6-k)
02/14/201709:01:48Report of Foreign Issuer (6-k)
02/14/201706:52:37Report of Foreign Issuer (6-k)
02/13/201712:47:11Report of Foreign Issuer (6-k)
02/10/201712:44:41Report of Foreign Issuer (6-k)

Glaxosmithkline and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations